Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Available × Eflornithine × CNS × Clear all

Status

Recruiting 5 Completed 3 Unknown 1 Available 1 Active not recruiting 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Typical Teratoid Rhabdoid Tumor 1 Neuroectodermal Tumors, Primitive 1 Neuroblastoma 1 Medulloblastoma 1

Interventions

3-Iodobenzylguanidine 4 ulixertinib 1 mirdametinib 1 carbon-11 methionine 1 Vaccination 1 Proton Pump Inhibitors 1 Methionine 1 Hydrocortisone 1 Eflornithine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03581240 2026-02-20

An Intermediate Expanded Use Trial of DFMO

Milton S. Hershey Medical Center

Typical Teratoid Rhabdoid Tumor, Medulloblastoma, Neuroblastoma, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡